Rare diseases Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Pompe disease"

The FDA ( Food and Drug Administration ) has announced the approval of Lumizyme ( Alglucosidase alfa ) for treatment of patients with infantile-onset Pompe disease, including patients who are less tha ...

A multicentre observational study was aimed to assess the prevalence of late-onset Pompe disease ( LOPD ) in a large high-risk population, using the dried blood spot ( DBS ) as a main screening tool. ...